Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "You Lu, MD"
8
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT05781932
Completed
Not Applicable
Innovative Suture Technique for Endoscopic Hernia Incision
Yizhuo Lu, MD
ClinicalTrials.gov
NCT05781932
Completed
Not Applicable
Innovative Suture Technique for Endoscopic Hernia Incision
Yizhuo Lu, MD
NCT06192979
Recruiting
Not Applicable
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Jin Lu, MD
ClinicalTrials.gov
NCT06192979
Recruiting
Not Applicable
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Jin Lu, MD
NCT06342466
Recruiting
Phase 2
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
Jin Lu, MD
ClinicalTrials.gov
NCT06342466
Recruiting
Phase 2
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
Jin Lu, MD
NCT05350943
Unknown
Phase 2
HAIC Combined With Toripalimab and Donafenib for Advanced BTC
Lu Wang, MD, PhD
ClinicalTrials.gov
NCT05350943
Unknown
Phase 2
HAIC Combined With Toripalimab and Donafenib for Advanced BTC
Lu Wang, MD, PhD
NCT05757336
Recruiting
Phase 2
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Lu Wang, MD, PhD
ClinicalTrials.gov
NCT05757336
Recruiting
Phase 2
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in U...
Lu Wang, MD, PhD
NCT06574880
Recruiting
Phase 1/2
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Angela Y. Jia, MD PhD
ClinicalTrials.gov
NCT06574880
Recruiting
Phase 1/2
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate...
Angela Y. Jia, MD PhD
NCT04917484
Recruiting
Phase 2
Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients
Tine Gregersen, MD
ClinicalTrials.gov
NCT04917484
Recruiting
Phase 2
Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patien...
Tine Gregersen, MD
NCT04543955
Terminated
Phase 2
Telotristat With Lutathera in Neuroendocrine Tumors
Lowell Anthony, MD
ClinicalTrials.gov
NCT04543955
Terminated
Phase 2
Telotristat With Lutathera in Neuroendocrine Tumors
Lowell Anthony, MD
Result Breakdown
Status
Recruiting
5 (63%)
Completed
1 (13%)
Unknown
1 (13%)
Terminated
1 (13%)
Phase
Phase 2
5 (63%)
not_applicable
2 (25%)
Phase 1/2
1 (13%)
Top Conditions
Medical Glue
1 (13%)
Suture Techniques
1 (13%)
AL Amyloidosis
1 (13%)
Show 7 more
Top Sponsors
Jin Lu, MD
2 (25%)
Lu Wang, MD, PhD
2 (25%)
Yizhuo Lu, MD
1 (13%)
Show 4 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease